Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Perlman

Showing results (261-270 of 273) with videos related to

Pageof 28
Sort By:
Orphanet Journal of Rare Diseases|November 15, 2013
Clinical characteristics of patients with spinocerebellar ataxias 1, 2, 3 and 6 in the US; a prospective observational studyTetsuo Ashizawa, Karla P Figueroa, Susan L Perlman, et al.
JAMA Cardiology|June 17, 2026
AAVrh.10hFXN Gene Therapy for the Cardiomyopathy of Friedreich Ataxia: A Nonrandomized Clinical TrialRonald G Crystal, Jonathan W Weinsaft, Stephen M Kaminsky, et al.
Annals of Neurology|April 24, 2012
FXN methylation predicts expression and clinical outcome in Friedreich ataxiaMarguerite V Evans-Galea, Nissa Carrodus, Simone M Rowley, et al.
Acta Neuropathologica|May 15, 2021
α-Synuclein in blood exosomes immunoprecipitated using neuronal and oligodendroglial markers distinguishes Parkinson's disease from multiple system atrophySuman Dutta, Simon Hornung, Adira Kruayatidee, et al.
Acta Neuropathologica|May 24, 2021
Correction to: α-Synuclein in blood exosomes immunoprecipitated using neuronal and oligodendroglial markers distinguishes Parkinson's disease from multiple system atrophySuman Dutta, Simon Hornung, Adira Kruayatidee, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 4, 2025
Spinocerebellar Ataxia Progression Measured with the Patient-Reported Outcome Measure of AtaxiaAnna L Burt, Gilbert L'Italien, Susan L Perlman, et al.
Cerebellum (London, England)|January 2, 2024
The Cerebellar Cognitive Affective/Schmahmann Syndrome Scale in Spinocerebellar AtaxiasLouisa P Selvadurai, Susan L Perlman, Tetsuo Ashizawa, et al.
Journal of Neurology|June 1, 2024
SARA captures disparate progression and responsiveness in spinocerebellar ataxiasEmilien Petit, Tanja Schmitz-Hübsch, Giulia Coarelli, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|August 15, 2016
HDQLIFE: development and assessment of health-related quality of life in Huntington disease (HD)N E Carlozzi, S G Schilling, J-S Lai, et al.
Cancer Medicine|June 2, 2023
Development of cancer surveillance guidelines in ataxia telangiectasia: A Delphi-based consensus survey of international expertsRenata Neves, Blanca De Dios Perez, Rafal Panek, et al.
Pageof 28

Showing results (261-270 of 273) with videos related to

Sort By:
Pageof 28
Orphanet Journal of Rare Diseases|November 15, 2013
Clinical characteristics of patients with spinocerebellar ataxias 1, 2, 3 and 6 in the US; a prospective observational studyTetsuo Ashizawa, Karla P Figueroa, Susan L Perlman, et al.
JAMA Cardiology|June 17, 2026
AAVrh.10hFXN Gene Therapy for the Cardiomyopathy of Friedreich Ataxia: A Nonrandomized Clinical TrialRonald G Crystal, Jonathan W Weinsaft, Stephen M Kaminsky, et al.
Annals of Neurology|April 24, 2012
FXN methylation predicts expression and clinical outcome in Friedreich ataxiaMarguerite V Evans-Galea, Nissa Carrodus, Simone M Rowley, et al.
Acta Neuropathologica|May 15, 2021
α-Synuclein in blood exosomes immunoprecipitated using neuronal and oligodendroglial markers distinguishes Parkinson's disease from multiple system atrophySuman Dutta, Simon Hornung, Adira Kruayatidee, et al.
Acta Neuropathologica|May 24, 2021
Correction to: α-Synuclein in blood exosomes immunoprecipitated using neuronal and oligodendroglial markers distinguishes Parkinson's disease from multiple system atrophySuman Dutta, Simon Hornung, Adira Kruayatidee, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 4, 2025
Spinocerebellar Ataxia Progression Measured with the Patient-Reported Outcome Measure of AtaxiaAnna L Burt, Gilbert L'Italien, Susan L Perlman, et al.
Cerebellum (London, England)|January 2, 2024
The Cerebellar Cognitive Affective/Schmahmann Syndrome Scale in Spinocerebellar AtaxiasLouisa P Selvadurai, Susan L Perlman, Tetsuo Ashizawa, et al.
Journal of Neurology|June 1, 2024
SARA captures disparate progression and responsiveness in spinocerebellar ataxiasEmilien Petit, Tanja Schmitz-Hübsch, Giulia Coarelli, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|August 15, 2016
HDQLIFE: development and assessment of health-related quality of life in Huntington disease (HD)N E Carlozzi, S G Schilling, J-S Lai, et al.
Cancer Medicine|June 2, 2023
Development of cancer surveillance guidelines in ataxia telangiectasia: A Delphi-based consensus survey of international expertsRenata Neves, Blanca De Dios Perez, Rafal Panek, et al.
Pageof 28